Department of Radiology, Endovascular Interventional Neuroradiology, The Methodist Hospital, Houston, Texas, USA.
Department of Neurosurgery, The Methodist Neurological Institute, Houston, Texas, USA.
World Neurosurg. 2014 Feb;81(2):322-9. doi: 10.1016/j.wneu.2012.12.011. Epub 2012 Dec 11.
The optimal treatment for middle cerebral artery (MCA) aneurysms is controversial. MCA aneurysms have been considered more conducive to surgical treatment. Recent technology has led to successful endovascular treatment of MCA aneurysms. The objective of this study was to analyze the outcomes of endovascular and surgical treatment of MCA aneurysms as experienced by a single tertiary center.
We retrospectively reviewed 90 MCA aneurysms in 84 patients treated from 2005 to 2010. They were separated into 2 groups: endovascular coiling, with 50 (59.5%) patients, and surgical clipping, with 34 (40.5%) patients. Outcome was based on complications, procedural morbidity and mortality, clinical and angiographic outcomes, and retreatment rates. Patients were further separated into ruptured and unruptured aneurysm groups.
Ruptured aneurysms were 10 of 50 (20%) and 9 of 34 (26.5%) patients in the endovascular and surgical groups, respectively. Procedure-related complications were 16% and 0% for the endovascular and surgical groups (P = .01), respectively. Overall rate of complete or near-complete occlusion at angiographic follow-up was 86% and 95% for the endovascular and surgical groups (P = .16), respectively. Proportion of patients with modified Rankin scale of 3 to 6 at 6 months follow-up was 10% and 5.9% for the endovascular and surgical groups (P = .5), respectively. The mean angiographic follow-up was 9.02 months (range 0 to 5.2 years). Retreatment rates were 14% and 0% for the endovascular and surgical groups, respectively (P = .01).
In this nonrandomized sample of 90 MCA aneurysms treated with endovascular coiling or neurosurgical clipping, we observed a similar clinical outcome based on the modified Rankin scale and angiographic occlusion. Complication and retreatment rates were higher but not significant for the endovascular group. Both treatment modalities are good alternatives and should be individualized based on aneurysm angioarchitecture and the patient's general conditions.
大脑中动脉(MCA)动脉瘤的最佳治疗方法存在争议。MCA 动脉瘤更有利于手术治疗。最近的技术已经成功地实现了 MCA 动脉瘤的血管内治疗。本研究的目的是分析单中心治疗的 MCA 动脉瘤的血管内和手术治疗结果。
我们回顾性分析了 2005 年至 2010 年期间治疗的 84 例患者的 90 个 MCA 动脉瘤。将它们分为两组:血管内线圈组,有 50 例(59.5%)患者;手术夹闭组,有 34 例(40.5%)患者。结果基于并发症、手术发病率和死亡率、临床和血管造影结果以及再治疗率。患者进一步分为破裂和未破裂动脉瘤组。
血管内组有 10 例(20%)和外科夹闭组有 9 例(26.5%)患者为破裂动脉瘤。与血管内组相比,手术组的手术相关并发症发生率为 16%,为 0%(P=0.01)。血管内组和手术组的完全或接近完全闭塞的血管造影随访率分别为 86%和 95%(P=0.16)。6 个月随访时改良 Rankin 量表评分 3 至 6 分的患者比例,血管内组为 10%,手术组为 5.9%(P=0.5)。平均血管造影随访时间为 9.02 个月(范围 0 至 5.2 年)。血管内组和手术组的再治疗率分别为 14%和 0%(P=0.01)。
在这项非随机样本中,90 例 MCA 动脉瘤分别采用血管内线圈栓塞或神经外科夹闭治疗,我们观察到基于改良 Rankin 量表和血管造影闭塞的相似临床结果。血管内组的并发症和再治疗率较高,但无统计学意义。两种治疗方法都是很好的选择,应根据动脉瘤血管解剖结构和患者的一般情况个体化。